Corporate calendar for ADC Therapeutics S.A. (ADCT): upcoming earnings dates, dividend ex-dates and payment dates, stock splits, shareholder meetings and conference calls. Plan your positions around the key catalysts.
ADC Therapeutics S.A. operates as a commercial-stage biotechnology company, focused on developing antibody-drug conjugates (ADCs) for the treatment of hematological malignancies and solid tumors. Its flagship product, ZYNLONTA, is presently being evaluated in multiple clinical trials: a Phase II study for relapsed or refractory diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma; a Phase III trial assessing its combination with rituximab for second-line, transplant-...
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|---|---|
| 2026-09-14 | $0.07 | $231M |
| 2026-09-14 | $-0.06 | $36M |
| 2026-09-14 | ||
| 2026-09-14 | ||
| 2026-09-14 | ||
| 2026-09-14 | $1M |
Price
| Price | $1.05 |
| Market Cap | $134M |
| Exchange | NYSE |
| Country | CH |
Analyst Consensus
| Strong Buy | 0 |
| Buy | 5 |
| Hold | 6 |
| Sell | 1 |
| Strong Sell | 0 |
| Total analysts | 12 |
| Avg rating (1-5) | 0.33 |
Related companies: ALMS · AUTL · BCYC · FDMT · LCTX · LXRX · NMRA
Explore sector: Healthcare · Biotechnology
More sections of ADCT: Overview · Financials · Valuation · Statistics · Estimates · Technical · Ownership · News
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks